Skip to main content

Table 2 Clinical characteristics and outcomes of children and adolescents with community acquired pneumonia

From: Etiology and the challenge of diagnostic testing of community-acquired pneumonia in children and adolescents

Variables

n/N (%)

Cough

513/525 (97.7)

  Productive

322/513 (62.7)

Fever

485/525 (92.4)

Dyspnea

398/525 (75.8)

Tachypneaa

256/518 (49.4)

Irritability

240/525 (45.7)

Somnolence

214/525 (40.8)

Diarrhea

135/525 (25.7)

Earache

50/525 (9.5)

Oxygen saturation < 90% at the time of hospital admission

176/453 (38.9)

Severity of community acquired pneumonia

  Non severe

376/525 (71.6)

  Severe

130/525 (24.8)

  Very severe

19/525 (3.6)

Complications

32/524 (6.1)

  Pleural effusion

22/524 (4.2)

  Acute respiratory distress syndrome

13/524 (2.5)

  Empyema

11/523 (2.1)

  Lung abscess

3/524 (0.6)

  Acute renal disease

1/524 (0.2)

Length of stay in days, median (IQR)

4 (3–6)

Admission to intensive care unit

22/524 (4.2)

 Mortality

0/525 (0.0)

  1. a ≥60 breath/min for children younger than 2 months; ≥50 for children between 2 to 11 months; ≥40 children between 1 to 5 years; ≥30 between 5 to 12 years; and > 20 for children older than 12 years